PReS-FINAL-2265: Tuberculosis in pediatric patients who are receiving anti-TNF agents
نویسندگان
چکیده
Methods Cohort observational study including pediatric patients receiving anti-TNFa agents in a tertiary-care pediatric hospital. LTI is ruled out by the implementation of antiTNFa drugs by tuberculin skin test (TST) and, from March 2012, QuantiFERON Gold-In Tube test (QTF). Along treatment, patients are evaluated periodically for TB using history and physical examination, but TST/ QTF are not systematically repeated.
منابع مشابه
Anti-TNF therapy in Jordan: a focus on severe infections and tuberculosis
BACKGROUND A high rate of infection has been reported in patients receiving treatment with anti-tumor necrosis factor (anti-TNF). This study describes the rate of and risk factors for serious infections in patients receiving anti-TNF agents in Jordan. METHODS This retrospective observational study was conducted at a large tertiary referral center in the north of Jordan. Between January 2006 a...
متن کاملIncidences of Serious Infections and Tuberculosis among Patients Receiving Anti-Tumor Necrosis Factor-α Therapy
PURPOSE Anti-tumor necrosis factor-alpha (TNF-α) medications represent a major advancement in the management of chronic inflammatory diseases. However, these agents are associated with increased risks of tuberculosis (TB) and other serious infections. The aim of this study was to evaluate the incidences of such disease among tertiary hospitals in Korea. MATERIALS AND METHODS We retrospectivel...
متن کاملPsoriasis, Anti-Tumor Necrosis Factor Therapy, and Tuberculosis: Report of Three Challenging Cases and Literature Review
INTRODUCTION The era of biologic therapies has provided new options for the treatment of chronic plaque psoriasis. However, safety concerns have led to intensive screening and monitoring of patients receiving anti-tumor necrosis factor alpha (anti-TNF-alpha) agents. METHODS The authors describe the cases of three patients with moderate to severe psoriasis treated with anti-TNF agents, with ch...
متن کاملDoes isoniazid chemoprophylaxis increase the frequency of hepatotoxicity in patients receiving anti-TNF-α agent with a disease-modifying antirheumatic drug?
OBJECTIVE The aim of this study is to determine the incidence of isoniazid (INH)-related hepatotoxicity in patients with rheumatologic diseases receiving tumor necrosis factor-α (TNF-α) antagonists along with a disease-modifying antirheumatic drug (DMARD). MATERIAL AND METHODS We have retrospectively evaluated 87 patients receiving anti-TNFα agents who were followed up between June 2005 and F...
متن کاملPReS-FINAL-2088: Risk of severe adverse events in juvenile idiopathic arthritis and pediatric-onset inflammatory bowel disease, treated with anti-tnf drugs
Methods This is a retrospective cohort study. All patients with JIA and IBD attending the “IRCCS Burlo Garofolo” of Trieste from 2000 to 2012 were enrolled. They were divided into 2 groups on the basis of the presence or absence of antitnf exposure. Severe adverse events were considered the followings: a) infections needing anti-tnf permanent suspension and/ or hospitalization; b) autoimmune di...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره 11 شماره
صفحات -
تاریخ انتشار 2013